Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein D3 (FOXD3) is a DNA-binding transcription factor of the forkhead box (FOX) family, characterized by the forkhead domain[1][5]. FOXD3 serves as a pivotal regulator of early development, pluripotency, neural crest lineage specification, and acts as a tumor suppressor. It functions as both a transcriptional repressor and activator, regulating gene expression and priming enhancers during development by recruiting chromatin remodelers and histone deacetylases[2][3]. In embryogenesis, FOXD3 maintains stem cell pluripotency and prevents premature differentiation. In the neural crest, it determines lineage fate and maintains progenitor pools. In pathology, FOXD3 loss or epigenetic silencing is associated with several diseases, including autoimmune disorders and cancers such as melanoma and gastric carcinoma[2][3].
Not applicable; as a transcription factor, FOXD3 is modulated indirectly; no known direct-acting drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein D3 (FOXD3).